# Aruba Aloë Formula F-BC-096 in the Treatment of Split Thickness Donor Sites After Wound Closure

> **NCT00389753** · NA · WITHDRAWN · sponsor: **University Hospital, Ghent**

## Conditions studied

- Hydration of Scars

## Interventions

- **DRUG:** Application of Aruba Aloë formula F-BC-096 or control

## Key facts

- **NCT ID:** NCT00389753
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study never started
- **Last updated:** 2021-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389753, "Aruba Aloë Formula F-BC-096 in the Treatment of Split Thickness Donor Sites After Wound Closure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00389753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*